查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1530410

女性不孕症诊断市场规模、份额、趋势分析报告：按测试、地区、细分预测，2024-2030

Female Infertility Diagnosis Market Size, Share & Trends Analysis Report By Test (Ovarian Reserve Testing, Hormone Testing, Hysterosalpingography, Other Tests), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

女性不孕症诊断市场趋势

2023年，全球女性不孕症诊断市场规模估计为44.5亿美元，预计2024年至2030年复合年增长率为8.6%。这个市场的成长是由生活方式的改变所推动的，生活方式的改变导致不孕症的增加和卵巢症候群（PCOS）等疾病的流行。根据世界卫生组织 (WHO) 2023 年 6 月发布的报告，PCOS 影响着约 8-13% 的育龄女性，而全球范围内，多达 70% 的受影响者尚未得到诊断。

例如，根据 2022 年 6 月《韩国医学杂誌》发表的一项研究，韩国在过去 30 年来的出生率是 OECD 国家中最低的。鑑于这一趋势，韩国政府认识到促进健康怀孕和生育的重要性，并正在采取措施应对少子化，并推出了“第四个应对少子老龄化社会基本计划”等倡议2021年。在支持高龄产妇怀孕的政策。因此，出生率下降预计将增加对不孕症诊断和辅助生殖技术的需求，从而扩大市场成长。

生活方式习惯对男性和女性的不孕症都有重大影响。吸烟、过量饮酒、不良饮食习惯和久坐的生活方式等因素会对生殖功能产生负面影响。此外，这些生活习惯可以透过多种机制影响生育能力，包括荷尔蒙失衡、氧化压力、发炎和生殖功能下降。根据世界卫生组织的数据，低收入和中等收入国家的不孕症盛行率为16.5%，高所得国家为17.8%。

全球女性不孕症诊断市场细分报告

该报告预测了2018年至2030年国家层级的收益成长，并对每个子区隔的最新行业趋势和商机进行了分析。在这项研究中，Grand View Research 根据测试和地区对女性不孕症诊断市场报告进行了细分：

  • 检查展望（销售，2018-2030）。
  • 卵巢储备测试。
  • 造影。
  • 激素测试。
  • 其他测试。
  • 区域展望（收入，2018-2030）。
  • 北美。

美国。

加拿大

墨西哥

  • 欧洲

英国

德国

法国

义大利

西班牙

丹麦

瑞典

挪威

  • 亚太地区

日本

中国

印度

澳洲

韩国

泰国

  • 拉丁美洲

巴西

阿根廷

  • 中东和非洲

南非

沙乌地阿拉伯

阿拉伯聯合大公国

科威特

目录

第一章调查方法和范围

第 2 章执行摘要

第三章女性不孕症诊断市场的变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 女性不孕症诊断市场分析工具
    • 波特五力分析
    • PESTEL分析

第四章女性不孕症诊断市场：测试估算与趋势分析

  • 细分仪表板
  • 女性不孕诊断市场：检测波动分析
  • 女性不孕症诊断市场：通过测试展望
  • 卵巢储备测试
  • 造影
  • 荷尔蒙测试
  • 其他测试

第五章 女性不孕诊断市场：区域估算及趋势分析

  • 区域仪表板
  • 按地区分類的女性不孕症诊断市场：重点
  • 北美洲
    • 2018-2030年北美女性不孕症诊断市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
    • 欧洲
    • 2018-2030年欧洲女性不孕症诊断市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030年亚太地区女性不孕症诊断市场估计与预测
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲女性不孕症诊断市场估计与预测
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 2018-2030年中东和非洲女性不孕症诊断市场估计与预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第六章 竞争状况

  • 市场参与企业分类
  • 公司市场分析
  • 主要企业简介
    • PFCLA
    • Mayo Foundation for Medical Education and Research（MFMER）
    • Cleveland Clinic
    • Apricity Fertility UK Limited
    • King's Fertility Limited
    • Dallas IVF
    • Midwest Fertility Specialists
    • Europe IVF
    • Care Fertility
    • Aspire Fertility
Product Code: GVR-4-68040-369-6

Female Infertility Diagnosis Market Trends

The global female infertility diagnosis market size was estimated at USD 4.45 billion in 2023 and is projected to grow at a CAGR of 8.6% from 2024 to 2030. The market's growth is driven by the growing changes in lifestyle, which contribute to the rise in infertility and the prevalence of conditions such as polycystic ovary syndrome (PCOS). According to a World Health Organization (WHO) report published in June 2023, PCOS affects approximately 8-13% of women of reproductive age, with up to 70% of those affected going undiagnosed globally.

Additionally, a constant increase in the incidence of infertility in both sexes is projected to drive the market.For instance, according to a study published in Journal of Korean Medical Science, in June 2022, South Korea has experienced the most significant decline in fertility rates among all OECD countries in the last three decades. The Korean government has acknowledged the importance of promoting healthy pregnancies and childbirth considering this trend and has introduced policies aimed at addressing the low fertility rate and supporting advanced maternal age pregnancies through initiatives such as 'The Fourth Basic Plan on Low Fertility and Aging Society' launched in 2021. Consequently, the low fertility rate is expected to drive up the demand for infertility diagnosis and assisted reproductive technologies, leading to an expansion in the market growth.

The lifestyle habits play a significant role in influencing fertility in both men and women. Factors such as smoking, excessive alcohol consumption, poor diet, and sedentary habits can have detrimental effects on reproductive health. In addition, these lifestyle habits can impact fertility through various mechanisms, including hormonal imbalances, oxidative stress, inflammation, and impaired reproductive function. According to WHO, prevalence of infertility is 16.5% in low & middle income countries and 17.8% in high income countries.

Global Female Infertility Diagnosis Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the female infertility diagnosis market report based on test and region:

  • Test Outlook (Revenue, USD Million, 2018 - 2030)
  • Ovarian Reserve Testing
  • Hysterosalpingography
  • Hormone testing
  • Other Tests
  • Region Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

  • Latin America

Brazil

Argentina

  • Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Tests
      • 1.1.1.2. Regional scope
    • 1.1.2. Estimates and forecasts timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.1.3. Purchased database
    • 1.1.4. GVR's internal database
    • 1.1.5. Secondary sources
    • 1.1.6. Primary research
    • 1.1.7. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.1.8. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.1.9. Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Female Infertility Diagnosis Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Female Infertility Diagnosis Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis

Chapter 4. Female Infertility Diagnosis Market: Tests Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Female Infertility Diagnosis Market: Tests Movement Analysis
  • 4.3. Female Infertility Diagnosis Market by Tests Outlook (USD Million)
  • 4.4. Ovarian Reserve Testing
    • 4.4.1. Ovarian Reserve Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Hysterosalpingography
    • 4.5.1. Hysterosalpingography Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Hormone Testing
    • 4.6.1. Hormone Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Other Tests
    • 4.7.1. Other Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Female Infertility Diagnosis Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Dashboard
  • 5.2. Regional Female Infertility Diagnosis Market: Key Takeaways
  • 5.3. North America
    • 5.3.1. North America Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key Country Dynamics
      • 5.3.2.2. Competitive Scenario
      • 5.3.2.3. Regulatory Framework
      • 5.3.2.4. Reimbursement scenario
      • 5.3.2.5. U.S. Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key Country Dynamics
      • 5.3.3.2. Competitive Scenario
      • 5.3.3.3. Regulatory Framework
      • 5.3.3.4. Reimbursement scenario
      • 5.3.3.5. Canada Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Mexico
      • 5.3.4.1. Key Country Dynamics
      • 5.3.4.2. Competitive Scenario
      • 5.3.4.3. Regulatory Framework
      • 5.3.4.4. Reimbursement scenario
      • 5.3.4.5. Mexico Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Europe
    • 5.3.6. Europe Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.7. UK
      • 5.3.7.1. Key Country Dynamics
      • 5.3.7.2. Competitive Scenario
      • 5.3.7.3. Regulatory Framework
      • 5.3.7.4. Reimbursement scenario
      • 5.3.7.5. UK Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.8. Germany
      • 5.3.8.1. Key Country Dynamics
      • 5.3.8.2. Competitive Scenario
      • 5.3.8.3. Regulatory Framework
      • 5.3.8.4. Reimbursement scenario
      • 5.3.8.5. Germany Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.9. France
      • 5.3.9.1. Key Country Dynamics
      • 5.3.9.2. Competitive Scenario
      • 5.3.9.3. Regulatory Framework
      • 5.3.9.4. Reimbursement scenario
      • 5.3.9.5. France Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.10. Italy
      • 5.3.10.1. Key Country Dynamics
      • 5.3.10.2. Competitive Scenario
      • 5.3.10.3. Regulatory Framework
      • 5.3.10.4. Reimbursement scenario
      • 5.3.10.5. Italy Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.11. Spain
      • 5.3.11.1. Key Country Dynamics
      • 5.3.11.2. Competitive Scenario
      • 5.3.11.3. Regulatory Framework
      • 5.3.11.4. Reimbursement scenario
      • 5.3.11.5. Spain Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.12. Denmark
      • 5.3.12.1. Key Country Dynamics
      • 5.3.12.2. Competitive Scenario
      • 5.3.12.3. Regulatory Framework
      • 5.3.12.4. Reimbursement scenario
      • 5.3.12.5. Denmark Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.13. Sweden
      • 5.3.13.1. Key Country Dynamics
      • 5.3.13.2. Competitive Scenario
      • 5.3.13.3. Regulatory Framework
      • 5.3.13.4. Reimbursement scenario
      • 5.3.13.5. Sweden Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.14. Norway
      • 5.3.14.1. Key Country Dynamics
      • 5.3.14.2. Competitive Scenario
      • 5.3.14.3. Regulatory Framework
      • 5.3.14.4. Reimbursement scenario
      • 5.3.14.5. Norway Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Japan
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Competitive Scenario
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. Reimbursement scenario
      • 5.4.2.5. Japan Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. China
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Competitive Scenario
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. Reimbursement scenario
      • 5.4.3.5. China Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. India
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Competitive Scenario
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. Reimbursement scenario
      • 5.4.4.5. India Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.5. South Korea
      • 5.4.5.1. Key Country Dynamics
      • 5.4.5.2. Competitive Scenario
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Reimbursement scenario
      • 5.4.5.5. South Korea Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.6. Australia
      • 5.4.6.1. Key Country Dynamics
      • 5.4.6.2. Competitive Scenario
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. Reimbursement scenario
      • 5.4.6.5. Australia Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.7. Thailand
      • 5.4.7.1. Key Country Dynamics
      • 5.4.7.2. Competitive Scenario
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Reimbursement scenario
      • 5.4.7.5. Thailand Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Latin America
    • 5.5.1. Latin America Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. Brazil
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Competitive Scenario
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. Reimbursement scenario
      • 5.5.2.5. Brazil Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Argentina
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Competitive Scenario
      • 5.5.3.3. Regulatory Framework
      • 5.5.3.4. Reimbursement scenario
      • 5.5.3.5. Argentina Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Middle East & Africa
    • 5.6.1. Middle East & Africa Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. South Africa
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Reimbursement scenario
      • 5.6.2.5. South Africa Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. Saudi Arabia
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. Reimbursement scenario
      • 5.6.3.5. Saudi Arabia Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. UAE
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Competitive Scenario
      • 5.6.4.3. Regulatory Framework
      • 5.6.4.4. Reimbursement scenario
      • 5.6.4.5. UAE Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.5. Kuwait
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Competitive Scenario
      • 5.6.5.3. Regulatory Framework
      • 5.6.5.4. Reimbursement scenario
      • 5.6.5.5. Kuwait Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Market Participant Categorization
  • 6.2. Company Market Position Analysis
  • 6.3. Key Company Profiles
    • 6.3.1. PFCLA
      • 6.3.1.1. Company overview
      • 6.3.1.2. Financial performance
      • 6.3.1.3. Service benchmarking
      • 6.3.1.4. Strategic initiatives
    • 6.3.2. Mayo Foundation for Medical Education and Research (MFMER)
      • 6.3.2.1. Company overview
      • 6.3.2.2. Financial performance
      • 6.3.2.3. Service benchmarking
      • 6.3.2.4. Strategic initiatives
    • 6.3.3. Cleveland Clinic
      • 6.3.3.1. Company overview
      • 6.3.3.2. Financial performance
      • 6.3.3.3. Service benchmarking
      • 6.3.3.4. Strategic initiatives
    • 6.3.4. Apricity Fertility UK Limited
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Service benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. King's Fertility Limited
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Service benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Dallas IVF
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Service benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Midwest Fertility Specialists
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Service benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Europe IVF
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Service benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. Care Fertility
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Service benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Aspire Fertility
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Service benchmarking
      • 6.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 4 North America Female Infertility Diagnosis market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 6 U.S. Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 7 Canada Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 8 Mexico Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 9 Europe Female Infertility Diagnosis market, by country, 2018 - 2030 (USD Million)
  • Table 10 Europe Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 11 UK Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 12 Germany Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 13 France Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 14 Italy Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 15 Spain Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 16 Norway Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 17 Sweden Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 18 Denmark Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific Female Infertility Diagnosis market, by country, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 21 Japan Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 22 China Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 23 India Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 24 Australia Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 25 South Korea Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 26 Thailand Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 27 Latin America Female Infertility Diagnosis market, by country, 2018 - 2030 (USD Million)
  • Table 28 Latin America Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 29 Brazil Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 30 Argentina Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 31 Middle East & Africa Female Infertility Diagnosis market, by country, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 33 South Africa Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 34 Saudi Arabia Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 35 UAE Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 36 Kuwait Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)

List of Figures

  • Fig 1. Information Procurement
  • Fig 2. Primary Research Pattern
  • Fig 3. Market Research Approaches
  • Fig 4. Value Chain-Based Sizing & Forecasting
  • Fig 5. Market Formulation & Validation
  • Fig 6. Female infertility diagnosis market segmentation
  • Fig 7. Market driver analysis (Current & future impact)
  • Fig 8. Market restraint analysis (Current & future impact)
  • Fig 9. Porter's Five Forces Analysis
  • Fig 10. PESTEL Analysis
  • Fig 11. Female infertility diagnosis market: Tests segment dashboard
  • Fig 12. Female infertility diagnosis market: Tests movement analysis, 2023 & 2030
  • Fig 13. Ovarian reserve testing products market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 14. Hysterosalpingography market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 15. Hormone testing market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 16. Other tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 17. Female infertility diagnosis market: Regional key takeaways (USD Million)
  • Fig 18. Female infertility diagnosis market regional outlook, 2023 & 2030, (USD Million)
  • Fig 19. North America female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 20. U.S. female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 21. Canada female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 22. Mexico female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 23. Europe female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 24. UK female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 25. Germany female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 26. France female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 27. Spain female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 28. Italy female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 29. Sweden female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 30. Norway female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 31. Denmark female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 32. Asia Pacific female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 33. China female infertility diagnosis estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 34. Japan female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 35. India female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 36. South Korea female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 37. Australia female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 38. Thailand female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 39. Latin America female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 40. Brazil female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 41. Argentina female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 42. Middle East and Africa female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 43. South Africa female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 44. Saudi Arabia female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 45. UAE female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 46. Kuwait female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)